Urologist Michael Trotter Treats 150th Patient with the UroLift® System for Enlarged Prostate

Share Article

Dr. Trotter, a UroLift Center of Excellence, has performed the most UroLift system treatments in Austin, Texas.

News Image
The UroLift System can be performed in office with local anesthesia and patients leave experiencing rapid symptom relief in days, instead of months

Michael Trotter, M.D., today announced that his 150th patient has been treated with the UroLift® System, a proven, minimally invasive technology to treat men suffering from symptoms associated with Benign Prostatic Hyperplasia, or BPH. Dr. Trotter is the first physician in Austin to reach this milestone, performing more UroLift System treatments than any other doctor in the area. He was also the first physician in Texas to become a UroLift Center of Excellence and the tenth nationwide.

“The UroLift System is changing the lives of many men,” says Dr. Trotter of Midtown Urology. “I am honored to offer a treatment option for BPH that allows men to discontinue the use of medication and is truly minimally invasive. The UroLift System can be performed in office with local anesthesia and patients leave experiencing rapid symptom relief in days, instead of months,” said Dr. Trotter. “The UroLift System is a top-of-the-line treatment option and I look forward to continuing to treat the many patients affected by enlarged prostate.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life. 

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring additional treatment for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery. 

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract’s FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the treatment. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://UroLift.com.

About Midtown Urology
Mission Midtown Urology Associates strives to provide each and every patient with comprehensive and timely state-of-the-art medical care. We pride ourselves on having highly trained and skilled urology professionals with a heightened focus on excellent customer service, compassionate care, advanced technology, convenience and an overall focus that includes operating our practice in a fiscally and ethically responsible manner. Our number one priority is to provide excellent care for each one our patients. Learn more at http://www.austinmidtownurology.com.

To schedule a consultation with Dr. Trotter, please call 512-451-7935. 

Media Contact:
Amy Cramer
(650) 391-3714
amy(at)healthandcommerce(dot)com

1 Roehrborn et al. EAU Abstract_ Eur Urol Suppl 2017; 16(3):e192. 
2 Sonksen et al J Urology 2016
MAC00359-01 RevB

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Serpa
Health & Commerce
+1 415-676-1923
Email >